NEL ASA | |
Stock Exchange | Boerse Berlin |
EPS |
- |
Market Cap |
EUR395.39 M |
Shares Outstanding |
1.1 B |
Public Float |
- |
NEL ASA | |
Stock Exchange | Oslo Stock Exchange |
EPS |
NOK0.19 |
Market Cap |
NOK9.3 B |
Shares Outstanding |
1.22 B |
Public Float |
1.02 B |
Address |
Karenslyst allé 20 Oslo PS 0278 Norway |
Employees | - |
Website | http://www.nel-asa.com |
Updated | 07/08/2019 |
NEL ASA develops diagnostic tests for the early detection of diseases based on gene expression signatures in blood samples. It operates through the In vitro diagnostic (IVD) and hydrogen segments. The In vitro diagnostic segment consists of developing innovative and patient friendly IVD products for early detection of diseases. |